Patents by Inventor Ryo TSUMURA

Ryo TSUMURA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230340176
    Abstract: Provided is a method for producing hollow resin particles in which a residual amount of a hydrocarbon solvent once held inside particles in a production process is reduced and particle breakage is suppressed. The method for producing hollow resin particles, which include preparing a mixture liquid containing a polymerizable monomer, a hydrocarbon solvent, a polymerization initiator and an aqueous medium, suspending the mixture liquid to prepare a suspension, subjecting the suspension to a polymerization reaction to prepare a precursor composition containing precursor particles having a hollow portion and including the hydrocarbon solvent in the hollow portion, and removing the hydrocarbon solvent from the precursor particles, wherein the polymerizable monomer contains a crosslinkable monomer in an amount of from 40% by mass to 100% by mass, and wherein the removal of the hydrocarbon solvent is performed by a specific method.
    Type: Application
    Filed: February 25, 2021
    Publication date: October 26, 2023
    Applicant: ZEON CORPORATION
    Inventor: Ryo Tsumura
  • Patent number: 11377504
    Abstract: The present invention provides an antibody beneficial for treatment of a solid tumor, an antibody-drug conjugate thereof, and an anticancer agent comprising these. The present invention provides, for example, an antibody that binds to tissue factor or an antigen-binding fragment thereof, wherein the antibody has a dissociation rate constant kd of 5×10?4 s?1 or more and an association rate constant Ka of 1×104 M?1 s?1 or more.
    Type: Grant
    Filed: October 29, 2018
    Date of Patent: July 5, 2022
    Assignees: National Cancer Center Japan, RIN Institute Inc.
    Inventors: Yasuhiro Matsumura, Masahiro Yasunaga, Shinji Saijo, Ryo Tsumura
  • Publication number: 20210221911
    Abstract: The present invention provides an antibody beneficial for treatment of a solid tumor, an antibody-drug conjugate thereof, and an anticancer agent comprising these. The present invention provides, for example, an antibody that binds to tissue factor or an antigen-binding fragment thereof, wherein the antibody has a dissociation rate constant kd of 5×10?4 s?1 or more and an association rate constant Ka of 1×104 M?1s?1 or more.
    Type: Application
    Filed: October 29, 2018
    Publication date: July 22, 2021
    Applicants: National Cancer Center Japan, RIN Institute Inc.
    Inventors: Yasuhiro MATSUMURA, Masahiro YASUNAGA, Shinji SAIJO, Ryo TSUMURA
  • Patent number: 10386739
    Abstract: The present invention is to provide a toner production method configured to prevent scale formation, be resistant to pipe clogging, and realize stable and efficient toner production, even in the case of long-term continuous production. Disclosed is a toner production method comprising: a dispersing step for obtaining a colorant dispersion by, in a stirring tank, (a) dispersing or dissolving a colorant and a charge control agent in a polymerizable monomer, or (b) dispersing or dissolving a binder resin, a colorant and a charge control agent in an organic solvent, and a droplets forming step by suspending the colorant dispersion in an aqueous dispersion medium, wherein, in the dispersing step, the binder resin, colorant or charge control agent is added to the polymerizable monomer or organic solvent in the stirring tank, from a hopper, through a pipe heated by a heating device.
    Type: Grant
    Filed: April 4, 2018
    Date of Patent: August 20, 2019
    Assignee: ZEON CORPORATION
    Inventors: Ryo Tsumura, Junichi Takashima, Fuminari Oyama
  • Publication number: 20190041764
    Abstract: The positively-chargeable black toner includes colored resin particles containing a binder resin, carbon black and, as a charge control resin, a quaternary ammonium salt group-containing copolymer, wherein the quaternary ammonium salt group-containing copolymer is a styrene acrylic polymer containing a quaternary ammonium salt group-containing (meth)acrylate monomer unit; wherein a copolymerization ratio of the quaternary ammonium salt group-containing (meth)acrylate monomer in the quaternary ammonium salt group-containing copolymer, is in a range of from 0.1% by mass to 2.5% by mass. A content of the carbon black is in a range of from 10 parts by mass to 15 parts by mass with respect to 100 parts by mass of the binder resin. A blow-off charge amount of the colored resin particles measured by a specific charge amount measuring method, is in a range of from 5 ?C/g to 60 ?C/g.
    Type: Application
    Filed: March 24, 2017
    Publication date: February 7, 2019
    Applicant: ZEON CORPORATION
    Inventor: Ryo Tsumura
  • Publication number: 20180292764
    Abstract: The present invention is to provide a toner production method configured to prevent scale formation, be resistant to pipe clogging, and realize stable and efficient toner production, even in the case of long-term continuous production. Disclosed is a toner production method comprising: a dispersing step for obtaining a colorant dispersion by, in a stirring tank, (a) dispersing or dissolving a colorant and a charge control agent in a polymerizable monomer, or (b) dispersing or dissolving a binder resin, a colorant and a charge control agent in an organic solvent, and a droplets forming step by suspending the colorant dispersion in an aqueous dispersion medium, wherein, in the dispersing step, the binder resin, colorant or charge control agent is added to the polymerizable monomer or organic solvent in the stirring tank, from a hopper, through a pipe heated by a heating device.
    Type: Application
    Filed: April 4, 2018
    Publication date: October 11, 2018
    Applicant: ZEON CORPORATION
    Inventors: Ryo Tsumura, Junichi Takashima, Fuminari Oyama
  • Patent number: 9920133
    Abstract: Monoclonal antibodies against human and mouse tissue factor, and fragments thereof, are disclosed, as well as pharmaceutical compositions and compositions for drug delivery containing the same. Therapeutic methods using the same are also disclosed.
    Type: Grant
    Filed: February 3, 2015
    Date of Patent: March 20, 2018
    Assignees: NATIONAL CANCER CENTER, The University of Tokyo, RIKEN, NanoCarrier Co., Ltd.
    Inventors: Yasuhiro Matsumura, Masahiro Yasunaga, Yoshikatsu Koga, Yoshiyuki Yamamoto, Ryuta Sato, Ryo Tsumura, Kazunori Kataoka, Nobuhiro Nishiyama, Yutaka Miura, Shino Manabe, Yasuki Kato
  • Publication number: 20170094467
    Abstract: A direction indicating device according to an embodiment includes: an orientation sensor that detects an orientation; a wireless communication device that receives orientation information; and a light emitting device. Furthermore, the direction indicating device includes a processor that controls the direction of light, generated by the light emitting device, in accordance with the angle that is formed by the detected orientation and the direction that is indicated by the received orientation information.
    Type: Application
    Filed: September 1, 2016
    Publication date: March 30, 2017
    Applicant: FUJITSU LIMITED
    Inventors: Keisuke KIUCHI, Hiroyuki Kawahara, Tatsuhiro SATO, Ryo Tsumura, Masahiro Tsukahara, Atsuji SEKIGUCHI, Yoshinobu Iwasato
  • Publication number: 20160333113
    Abstract: Monoclonal antibodies against human and mouse tissue factor, and fragments thereof, are disclosed, as well as pharmaceutical compositions and compositions for drug delivery containing the same. Therapeutic methods using the same are also disclosed.
    Type: Application
    Filed: February 3, 2015
    Publication date: November 17, 2016
    Applicants: NATIONAL CANCER CENTER, The University of Tokyo, RIKEN, NanoCarrier Co., Ltd.
    Inventors: Yasuhiro MATSUMURA, Masahiro YASUNAGA, Yoshikatsu KOGA, Yoshiyuki YAMAMOTO, Ryuta SATO, Ryo TSUMURA, Kazunori KATAOKA, Nobuhiro NISHIYAMA, Yutaka MIURA, Shino MANABE, Yasuki KATO